3 ms·
The Monsanto Papers: MDL Glyphosate Cancer Case Key Documents and Analysis
- Natsu 9y agoThis is some more directly sourced information as a follow-up to the prior story on HN: https://news.ycombinator.com/item?id=14659301 https://news.ycombinator.com/item?id=14659301 The email that was the subject of the previous story is in this dump, in a thread starting on p. 99 of this PDF: https://usrtk.org/wp-content/uploads/2017/03/JessRowlandseries.pdf https://usrtk.org/wp-content/uploads/2017/03/JessRowlandseri... Below is a quick transcription of the email referenced in the prior article: === Hey- cc'ing Jen So...Jess called me out of the blue this morning: "We have enough to sustain our conclusions. Don't need gene tox or epi. The only thing is the cheminova study with the sarcoma in mice- we have that study now and its conclusions are irrelevant (bc at limit dose...?) I am the chair of the CARC and my folks are running this process for glyphosate in reg review. I have called a CARC meeting in June..." Also, Jess called to ask for a contact name at ATSDR. I passed on Jesslyn's email. He told me no coordination is going on and he wanted to establish some saying "If I can kill this I should get a medal". However, don't get your hopes up, I doubt EPA and Jess can kill this; but it's good to know they are going to actually make the effort now to coordinate due to our pressing and their shared concern that ATSDR is consistent in its conclusions w EPA. Dan Jenkins U.S. Agency Lead Regulatory Affairs Monsasnto Company 1300 I St., NW Suite 450 East Washington, DC 20005 Office: 202-383-2851 Cell: 571-732-6575